Fidia Farmaceutici wins ‘2023 Best Aesthetic Regenerative Medicine product’ Award
Fidia Farmaceutici received the “2023 AMWC Aesthetic Medicine Awards” in the ‘Aesthetic Regenerative Medicine’ category, at a ceremony held in Monaco on March 31st, during the 21st edition of AMWC World Congress that took place in Monaco between March 30th and April 1st.
Now in its 9th edition, the AMWC Aesthetic Medicine Awards is an annual competition that rewards doctors and companies that aspire to innovation and excellence in aesthetics. The Award enriches the prestigious Aesthetic and Anti-Aging Medicine World Congress (AMWC), the leading industry event attended by 15,000 participants, 300 exhibitors and 300 speakers each year.
The awards are granted by a jury of world-renowned doctors in aesthetic medicine, who choose the winners based on originality, creativity, and product innovation.
Hy-Tissue PRP is a sterile, disposable medical device used in the clinic to carry out the collection of a defined amount of uncoagulated blood by means of centrifugation, so as to obtain Platelet-Rich Plasma (PRP) in a closed system for autologous applications.
The CEO of Fidia, Carlo Pizzocaro, stated “This valuable recognition by the international society of top physicians is both rewarding and reassuring of our commitment in aesthetic field. With patients’ and physicians’ needs at our core, our innovation will continue to evolve and bring the best solutions into the market”.